Amplia Therapeutics Ltd. (AU:ATX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Amplia Therapeutics Limited has announced the application for quotation of 1,821,508 new fully paid ordinary securities on the ASX under the code ATX, effective from July 17, 2024. The application signifies potential growth and investment opportunities for stakeholders in the biotechnological sector.
For further insights into AU:ATX stock, check out TipRanks’ Stock Analysis page.